|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.00 INR | +1.60% |
|
+2.76% | +3.32% |
Company Valuation: Vineet Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 439.3 | 381.7 | 446.2 | 287.6 |
| Change | - | -13.12% | 16.91% | -35.54% |
| Enterprise Value (EV) 1 | 523.3 | 686.2 | 886.9 | 685 |
| Change | - | 31.15% | 29.24% | -22.76% |
| P/E | 6.62x | 30.5x | 43.6x | -1.42x |
| PBR | 1.32x | 1.13x | 1.28x | 1.96x |
| PEG | 0x | -0.4x | -2.4x | 0x |
| Capitalization / Revenue | 2,29,785x | 1,79,783x | 2,95,567x | 3,73,778x |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | - | - | - |
| EV / EBIT | 4.66x | 12.2x | 17.5x | -4.07x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | 1 | - | - | - |
| Rate of return | 2.1% | - | - | - |
| EPS 2 | 7.201 | 1.359 | 1.11 | -21.9 |
| Distribution rate | 13.9% | - | - | - |
| Net sales | 1,912 | 2,123 | 1,510 | 769.5 |
| EBITDA | 132.4 | 79.97 | 74.27 | -143.3 |
| EBIT 1 | 112.3 | 56.24 | 50.54 | -168.3 |
| Net income 1 | 66.39 | 12.52 | 10.27 | -201.9 |
| Net Debt 1 | 83.97 | 304.6 | 440.7 | 397.4 |
| Reference price 2 | 47.65 | 41.40 | 48.40 | 31.20 |
| Nbr of stocks (in thousands) | 9,219 | 9,219 | 9,219 | 9,219 |
| Announcement Date | 05/09/22 | 05/09/23 | 04/09/24 | 02/09/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 74.17L | ||
| 35.39x | 12.58x | 26.43x | 0.57% | 1,05700Cr | ||
| 27.79x | 6.35x | 17.58x | 2.07% | 62TCr | ||
| 33.47x | 7.59x | 15.59x | 2.68% | 45TCr | ||
| 20.98x | 4.63x | 11.4x | 2.86% | 34TCr | ||
| 21.62x | 5.7x | 13.97x | 2.82% | 30TCr | ||
| 21.08x | 4.45x | 12.3x | 1.98% | 26TCr | ||
| 14.13x | 5.26x | 10.83x | 3.54% | 22TCr | ||
| 24.37x | 6.41x | 11.32x | 2.71% | 20TCr | ||
| -47.14x | 5.65x | 31.2x | 2.52% | 16TCr | ||
| Average | 16.85x | 6.51x | 16.74x | 2.42% | 36.14TCr | |
| Weighted average by Cap. | 24.72x | 7.88x | 18.52x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VINEETLAB Stock
- Valuation Vineet Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















